옵션 체인은 다양한 행사가격과 만기일에 대한 Biodexa Pharmaceuticals의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Biodexa Pharmaceuticals에 대한 시장 심리를 평가합니다..

Biodexa Pharmaceuticals (NASDAQ:BDRX) 주식, 옵션 체인

Biodexa Pharmaceuticals

Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals PLC

BOMBARDIER 6.25% PFD A by Bombardier Inc.

Bombardier Inc

EV giant Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) will launch the Performance variant of its <a href="https://www.benzinga.com/tech/25/02/43419132/tesla-begins-global-production-of-refreshed-model-y-deliveries-start-in-march">refreshed Model Y</a> later in the year, company executive Lars Moravy said in an interview published on Monday.
What Happened: Tesla launched the refreshed version of its best-selling Model Y SUV in January. The launch series (vehicle with exclusive badging and more that the company intends to make to celebrate the start of production) long-range all-wheel drive variant of the refreshed vehicle is currently listed on Tesla&#8217;s U.S. website alongside the older variants of the vehicle. 
However, other variants of the refreshed vehicle, including the premium Performance variant, will be launched later this year, according to Moravy. 
&#8220;Actually we&#8217;re starting with the launch edition and then all of the other variants the dual motor, base edition rear-wheel drive, performance, and seven-seater options, those will come later in the year,&#8221; Moravy, Vice President of Vehicle Engineering, said in an episode of Jay Leno&#8217;s Garage premiered on YouTube on Monday. 
Tesla commenced production of the refreshed vehicle less than two weeks ago across its four vehicle factories around the world in Califonia, Texas, Shanghai, and Berlin. Deliveries of the vehicle are slated to start in March. 
Why It Matters: Tesla CEO&nbsp;Elon Musk&nbsp;said during the company&#8217;s earnings call last month that the company will&nbsp;<a href="https://www.benzinga.com/25/01/43328898/elon-musk-warns-teslas-new-model-y-will-result-in-several-weeks-of-lost-production-for-ev-giant-in-q1" target="_blank" rel="noreferrer noopener">lose production in the days of retooling </a>factories to prepare for production of the refreshed vehicle. 
The CEO also warned that margins will be impacted due to idle capacity and other ramp-related costs. However, these challenges will be overcome once production is ramped, he said.
Model Y is Tesla&#8217;s best-selling vehicle. The refreshed vehicle&#8217;s launch follows the company reporting a fall in vehicle deliveries for the first time in over a decade.
Tesla reported global&nbsp;<a href="https://www.benzinga.com/trading-ideas/movers/25/01/42766117/tesla-stock-tumbles-on-q4-deliveries-whats-going-on" target="_blank" rel="noreferrer noopener">deliveries of 1.79 million</a>&nbsp;vehicles in 2024, down from full-year deliveries of 1.81 million in 2023.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43588718/lucid-ceo-envisions-ev-maker-licensing-tech-more-than-building-cars" target="_blank" rel="noreferrer noopener">Peter Rawlinson Wants Lucid To Be The Intel Of EVs: ‘You Flash Your Microsoft Office… Bill Gates Gets His Royalty… I Want To Be Like That'</a></li>
</ul>
Photo courtesy: Tesla

News

Tech

TSLA

Elon Musk's Tesla To Launch Performance Variant Of Refreshed Model Y 'Later This Year'

CSCO

Cisco Launches New Smart Switches With Intelligent Networking Silicon Alongside Embedded DPUs To Redefine AI Data Center Designs.

<h3>Companies Reporting Before The Bell</h3>
• Royalty Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPRX#NASDAQ">RPRX</a>) is estimated to report quarterly earnings at $1.05 per share on revenue of $743.60 million. 
• AutoNation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) is likely to report quarterly earnings at $4.26 per share on revenue of $6.81 billion. 
• Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) is estimated to report quarterly loss at $2.12 per share on revenue of $28.84 billion. 
• Carrier Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>) is projected to report quarterly earnings at $0.48 per share on revenue of $5.20 billion. 
• DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) is projected to report quarterly earnings at $0.98 per share on revenue of $3.07 billion. 
• BP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $45.65 billion. 
• Yatra Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTRA#NASDAQ">YTRA</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $15.02 million. 
• NNN REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNN#NYSE">NNN</a>) is estimated to report quarterly earnings at $0.82 per share on revenue of $217.60 million. 
• OrganiGram Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) is projected to report quarterly loss at $0.03 per share on revenue of $48.93 million. 
• Arvinas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) is estimated to report quarterly loss at $1.04 per share on revenue of $59.49 million. 
• Orion Energy Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OESX#NASDAQ">OESX</a>) is expected to report quarterly loss at $0.01 per share on revenue of $26.52 million. 
• Jerash Holdings (US) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRSH#NASDAQ">JRSH</a>) is expected to report quarterly loss at $0.01 per share on revenue of $37.65 million. 
• Ceragon Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNT#NASDAQ">CRNT</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $105.16 million. 
• SolarWinds (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWI#NYSE">SWI</a>) is expected to report quarterly earnings at $0.27 per share on revenue of $202.91 million. 
• Curbline Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURB#NYSE">CURB</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $28.88 million. 
• IPG Photonics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPGP#NASDAQ">IPGP</a>) is projected to report quarterly earnings at $0.22 per share on revenue of $229.47 million. 
• LCI Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LCII#NYSE">LCII</a>) is projected to report quarterly earnings at $0.31 per share on revenue of $799.81 million. 
• Sequans Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQNS#NYSE">SQNS</a>) is likely to report quarterly loss at $0.07 per share on revenue of $10.50 million. 
• Sunoco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUN#NYSE">SUN</a>) is likely to report quarterly earnings at $1.34 per share on revenue of $5.92 billion. 
• WK Kellogg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLG#NYSE">KLG</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $650.00 million. 
• Fidelity National Info (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) is projected to report quarterly earnings at $1.36 per share on revenue of $2.63 billion. 
• Marriott Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) is likely to report quarterly earnings at $2.36 per share on revenue of $6.39 billion. 
• MYT Netherlands Parent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYTE#NYSE">MYTE</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $217.77 million. 
• Shopify (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) is projected to report quarterly earnings at $0.43 per share on revenue of $2.73 billion. 
• WESCO Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WCC#NYSE">WCC</a>) is expected to report quarterly earnings at $3.23 per share on revenue of $5.42 billion. 
• TPG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) is projected to report quarterly earnings at $0.52 per share on revenue of $463.18 million. 
• USA Compression Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USAC#NYSE">USAC</a>) is expected to report quarterly earnings at $0.27 per share on revenue of $242.95 million. 
• S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) is projected to report quarterly earnings at $3.41 per share on revenue of $3.46 billion. 
• Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) is expected to report quarterly earnings at $0.52 per share on revenue of $10.70 billion. 
• Leidos Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) is projected to report quarterly earnings at $2.27 per share on revenue of $4.13 billion. 
• Masco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>) is estimated to report quarterly earnings at $0.87 per share on revenue of $1.84 billion. 
• GLOBALFOUNDRIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $1.83 billion. 
• Ecolab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) is expected to report quarterly earnings at $1.81 per share on revenue of $4.03 billion. 
<h3>Companies Reporting After The Bell</h3>
• Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) is likely to report quarterly earnings at $1.70 per share on revenue of $7.15 billion. 
• Monarch Casino &amp; Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRI#NASDAQ">MCRI</a>) is projected to report quarterly earnings at $1.06 per share on revenue of $129.03 million. 
• Avis Budget Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) is projected to report quarterly loss at $1.03 per share on revenue of $2.73 billion. 
• Franklin Street Props (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FSP#AMEX">FSP</a>) is projected to report quarterly loss at $0.07 per share on revenue of $30.83 million. 
• Edwards Lifesciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) is projected to report quarterly earnings at $0.55 per share on revenue of $1.49 billion. 
• Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) is projected to report quarterly earnings at $0.63 per share on revenue of $5.78 billion. 
• Evolution Petroleum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EPM#AMEX">EPM</a>) is likely to report quarterly earnings at $0.02 per share on revenue of $22.73 million. 
• Bioceres Crop Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOX#NASDAQ">BIOX</a>) is expected to report quarterly earnings at $0.15 per share on revenue of $144.62 million. 
• Genasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNSS#NASDAQ">GNSS</a>) is projected to report quarterly loss at $0.16 per share on revenue of $6.59 million. 
• Everus Construction Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECG#NYSE">ECG</a>) is expected to report earnings for its fourth quarter. 
• United Fire Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFCS#NASDAQ">UFCS</a>) is likely to report quarterly earnings at $0.66 per share on revenue of $327.70 million. 
• Tigo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TYGO#NASDAQ">TYGO</a>) is estimated to report quarterly loss at $0.16 per share on revenue of $15.62 million. 
• HIVE Digital Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIVE#NASDAQ">HIVE</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $28.48 million. 
• Atomera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) is likely to report quarterly loss at $0.14 per share on revenue of $500 thousand. 
• Sage Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) is projected to report quarterly loss at $1.38 per share on revenue of $14.11 million. 
• Exelixis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) is expected to report quarterly earnings at $0.48 per share on revenue of $562.72 million. 
• Forrester Res (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORR#NASDAQ">FORR</a>) is projected to report quarterly earnings at $0.34 per share on revenue of $106.25 million. 
• BlackLine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BL#NASDAQ">BL</a>) is projected to report quarterly earnings at $0.50 per share on revenue of $168.10 million. 
• Primerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRI#NYSE">PRI</a>) is likely to report quarterly earnings at $4.90 per share on revenue of $766.63 million. 
• Allison Transmission (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>) is likely to report quarterly earnings at $1.91 per share on revenue of $765.40 million. 
• Electromed (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELMD#AMEX">ELMD</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $15.30 million. 
• W.P. Carey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPC#NYSE">WPC</a>) is estimated to report quarterly earnings at $1.20 per share on revenue of $397.32 million. 
• Sensata Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) is estimated to report quarterly earnings at $0.75 per share on revenue of $883.43 million. 
• Pitney Bowes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) is projected to report quarterly earnings at $0.14 per share on revenue of $509.65 million. 
• America Movil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMX#NYSE">AMX</a>) is expected to report quarterly earnings at $0.38 per share on revenue of $12.27 billion. 
• Eversource Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ES#NYSE">ES</a>) is expected to report quarterly earnings at $1.02 per share on revenue of $3.13 billion. 
• Adaptive Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) is expected to report quarterly loss at $0.24 per share on revenue of $45.84 million. 
• Anterix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEX#NASDAQ">ATEX</a>) is expected to report quarterly loss at $0.61 per share on revenue of $1.88 million. 
• IAC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) is likely to report quarterly earnings at $0.39 per share on revenue of $934.31 million. 
• Mercury General (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCY#NYSE">MCY</a>) is estimated to report quarterly earnings at $0.64 per share on revenue of $1.23 billion. 
• American Intl Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>) is expected to report quarterly earnings at $1.53 per share on revenue of $6.70 billion. 
• Diodes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DIOD#NASDAQ">DIOD</a>) is estimated to report quarterly earnings at $0.32 per share on revenue of $337.10 million. 
• Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) is projected to report quarterly loss at $0.01 per share on revenue of $1.55 billion. 
• Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $532.04 million. 
• Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $533.26 million. 
• Teradata (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDC#NYSE">TDC</a>) is projected to report quarterly earnings at $0.44 per share on revenue of $417.67 million. 
• DoubleDown Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDI#NASDAQ">DDI</a>) is projected to report quarterly earnings at $0.58 per share on revenue of $85.54 million. 
• Similarweb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMWB#NYSE">SMWB</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $65.48 million. 
• OneStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OS#NASDAQ">OS</a>) is likely to report quarterly earnings at $0.02 per share on revenue of $128.13 million. 
• MRC Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $726.90 million. 
• Mirion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MIR#NYSE">MIR</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $245.02 million. 
• Upstart Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $181.92 million. 
• Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) is projected to report quarterly earnings at $1.12 per share on revenue of $2.12 billion. 
• Silvercorp Metals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SVM#AMEX">SVM</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $80.90 million. 
• Kite Realty Gr Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRG#NYSE">KRG</a>) is projected to report quarterly earnings at $0.53 per share on revenue of $209.12 million. 
• Gladstone Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLAD#NASDAQ">GLAD</a>) is likely to report quarterly earnings at $0.53 per share on revenue of $24.40 million. 
• InvenTrust Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVT#NYSE">IVT</a>) is likely to report quarterly earnings at $0.41 per share on revenue of $71.16 million. 
• Angi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $254.21 million. 
• Energy Transfer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) is projected to report quarterly earnings at $0.38 per share on revenue of $21.43 million. 
• Red Rock Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRR#NASDAQ">RRR</a>) is projected to report quarterly earnings at $0.52 per share on revenue of $491.36 million. 
• Assurant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIZ#NYSE">AIZ</a>) is likely to report quarterly earnings at $3.51 per share on revenue of $3.08 billion. 
• Acadia Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKR#NYSE">AKR</a>) is likely to report quarterly earnings at $0.33 per share on revenue of $83.33 million. 
• Brighthouse Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHF#NASDAQ">BHF</a>) is estimated to report quarterly earnings at $4.58 per share on revenue of $2.22 billion. 
• Highwoods Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIW#NYSE">HIW</a>) is projected to report quarterly earnings at $0.86 per share on revenue of $203.87 million. 
• Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $189.30 million. 
• DoorDash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) is projected to report quarterly earnings at $0.33 per share on revenue of $2.84 billion. 
• Agree Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>) is projected to report quarterly earnings at $1.03 per share on revenue of $156.13 million. 
• Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $256.84 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

ADPT

ALSN

ANGI

ARVN

ATEX

ATOM

Brighthouse Financial, Inc. - Common Stock

BIOX

CARR

CFLT

CRNT

CURB

DASH

DIOD

ELMD

EXEL

FORR

FRSH

GILD

GLAD

GNSS

HIVE

IPGP

JRSH

LCII

LDOS

LYFT

MCRI

MYTE

OESX

RPRX

SAGE

SHOP

SMCI

SMWB

SPGI

SQNS

TYGO

UFCS

UPST

USAC

WELL

YTRA

Earnings Scheduled For February 11, 2025

General

ERIC

Ericsson's New Venture Aduna Forms Partnership With Sinch To Strengthen The Network API Ecosystem

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index moved to the &#8220;Neutral&#8221; zone on Monday.
U.S. stocks settled higher on Monday, with the Nasdaq Composite surging around 1% during the session as investors set aside tariff threats by President Donald Trump. Shares of chipmakers gained on Monday, with Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) adding 2.9% during the session. Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) and Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) rose 4.5% and 3.9%, respectively, during the session.
Wall Street, meanwhile, recorded losses last week as renewed fears over inflation and trade tariffs eroded risk appetite.
Shares of ON Semiconductor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) dipped over 8% on Monday after the company posted downbeat quarterly results. Shares of McDonald&#8217;s Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) gained around 5% following the release of fourth-quarter results.
On the economic data front, U.S. consumer inflation expectations for the year ahead came in steady for a third straight month at 3% in January.
Most sectors on the S&amp;P 500 closed on a positive note, with energy, information technology, and utilities stocks recording gains on Monday. However, financial and utilities stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 167 points to 44,470.41 on Monday. The S&amp;P 500 rose 0.67% to 6,066.44, while the Nasdaq Composite gained 0.98% at 19,714.27 during Monday's session.
Investors are awaiting earnings results from The Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), Marriott International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>), and Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 46.2, the index moved to the &#8220;Neutral&#8221; zone on Monday, versus a prior reading of 38.8.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

AVGO

NVDA

Nasdaq Gains 1% As Nvidia, Broadcom Surge: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone

AMD Inks Letter of Intent With French Alternative Energies And Atomic Energy Commission (CEA) To Partner On The Future Of AI Compute

Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) will release its fourth-quarter financial results, before the opening bell, on <a href="https://www.benzinga.com/quote/SHOP/earnings">Tuesday, Feb. 11, 2025</a>.
Analysts expect the Ottawa, Canada-based company to report quarterly earnings at 43 cents per share, up from 34 cents per share in the year-ago period. Shopify projects quarterly revenue of $2.73 billion, compared to $2.14 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 7, EMERGE Commerce Ltd announced the sale of its premium web domains, Shop.ca and Shop.us, to Shopify for $375,000, or around CA$536,000.
Shopify shares gained 2.1% to close at $119.90 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/GBX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>RBC Capital analyst Paul Treiber reiterated an Outperform rating with a price target of $130 on Jan. 22, 2025. This analyst has an accuracy rate of 74%.</li>
<li>Wedbush analyst Scott Devitt upgraded the stock from Neutral to Outperform and raised the price target from $115 to $125 on Jan. 6, 2025. This analyst has an accuracy rate of 84%.</li>
<li>JMP Securities analyst Andrew Boone reiterated a Market Outperform rating with a price target of $120 on Dec. 12, 2024. This analyst has an accuracy rate of 82%.</li>
<li>MoffettNathanson analyst Michael Morton maintained a Neutral rating and raised the price target from $86 to $99 on Nov. 26, 2024. This analyst has an accuracy rate of 69%.</li>
<li>Oppenheimer analyst Ken Wong maintained an Outperform rating and boosted the price target from $90 to $130 on Nov. 13, 2024. This analyst has an accuracy rate of 81%.</li>
</ul>
Considering buying SHOP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image is-resized"><img decoding="async" src="blob:https://editorial.benzinga.com/986ef8f1-9979-4b55-b888-9ceb68d9a9c6" alt="" style="width:609px;height:auto" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>

Price Target

Analyst Ratings

Shopify Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Whales collected hundreds of millions of dollars in Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), capitalizing on the world&#8217;s second-largest cryptocurrency&#8217;s subdued rates.
What Happened: Two substantial Ethereum withdrawals from cryptocurrency exchanges were reported by on-chain tracking platform Lookonchain in a Monday X post.
The first withdrawal involved 56,909 ETH, worth 151.6 million, from Binance, while the second whale accumulated a combined 64,603 ETH, valued at $171.8 million, from Binance and Bitfinex. Both transactions occurred within a 48-hour window.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">It seems that whales are accumulating <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a>! 0xb99a&#8230;BcF5 withdrew 56,909 <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a>($151.6M) from <a href="https://twitter.com/hashtag/Binance?src=hash&amp;ref_src=twsrc%5Etfw">#Binance</a> 4 hours ago. 0xEd0C&#8230;4312 withdrew 64,603 <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a>($171.8M) from <a href="https://twitter.com/hashtag/Binance?src=hash&amp;ref_src=twsrc%5Etfw">#Binance</a> and <a href="https://twitter.com/hashtag/Bitfinex?src=hash&amp;ref_src=twsrc%5Etfw">#Bitfinex</a> in the past 48 hours.<a href="https://t.co/hLMs0ziEUI">https://t.co/hLMs0ziEUI</a><a href="https://t.co/TXrSYqOSKQ">https://t.co/TXrSYqOSKQ</a> <a href="https://t.co/a6Oe20q946">pic.twitter.com/a6Oe20q946</a>
&mdash; Lookonchain (@lookonchain) <a href="https://twitter.com/lookonchain/status/1889169910032650631?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
These withdrawals were part of a market-wide phenomenon, as Ethereum recorded net exchange outflows of over $51 million in the last 24 hours, <a href="https://app.intotheblock.com/?end_offset=20">according </a>to data from IntoTheBlock. Typically, when more funds exit exchanges than they enter, it suggests a bullish outlook. 
Additionally, a 16% jump in transactions valued over $100,000 indicated a renewed interest among whale investors in accumulating ETH.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/02/43584910/man-who-accidentally-lost-his-775-million-bitcoin-stash-expresses-desire-to-buy-the-landfill-site">Man Whose $775 Million Bitcoin Fortune Lies Buried In A Landfill Now Wants To Buy The Trash Heap</a>
Why It Matters: The accumulation by large investors comes at a time when Wall Street hedge funds <a href="https://in.benzinga.com/markets/cryptocurrency/25/02/43586765/wall-streets-ethereum-short-positioning-skyrockets-the-extreme-positioning-has-caused-eth-to-underperform-bitcoin-says-analyst">have been increasingly betting against ETH</a>. A report suggested that the short positioning has surged by 40% in a week&#8217;s time and 500% since November. 
ETH was also the least popular of the three largest cryptocurrencies, <a href="https://trends.google.com/trends/explore?date=today%201-m&amp;geo=US&amp;q=ethereum,XRP,Bitcoin&amp;hl=en">according </a>to Google Trends data, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) generating much higher search interest.
Interestingly, Eric Trump, President Donald Trump&#8217;s son, <a href="https://in.benzinga.com/markets/cryptocurrency/25/02/43484922/bitcoin-ethereum-dogecoin-drops-as-trumps-crypto-czar-announces-oversight-committee-eric-trump-says-great-time-to-add-eth">suggested last week on X</a> that "it's a great time to add ETH," potentially influencing decisions of certain players.
Price Action: At the time of writing, Ethereum was exchanging hands at $2,716.83, up 3.25% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>. Year-to-date, the coin has endured losses of over 18%.
Image via Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43581896/analyst-who-nailed-2021-crypto-collapse-now-says-worst-of-bitcoin-could-come-in-next-few-weeks">Analyst Who Nailed 2021 Crypto Collapse Now Says Worst Of Bitcoin Could Come In Next Few Weeks</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Movers

$BTC

$ETH

$SOL

$XRP

Week After Eric Trump Said 'Great Time To Add ETH,' Whales Stock Up Over $300 Million In Ethereum — What's Cooking

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects The Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) to report quarterly earnings at 52 cents per share on revenue of $10.68 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Coca-Cola shares gained 0.1% to $64.63 in after-hours trading.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) reported better-than-expected earnings for its fourth quarter but issued weak guidance for the first quarter. The company said it sees first-quarter adjusted earnings of 2 cents to 8 cents per share, versus estimates of 14 cents per share. The company expects revenue of $120 million to $135 million versus projections of $154.76 million. Harmonic shares dipped 29% to $7.90 in the after-hours trading session.</li>
<li>Analysts are expecting Marriott International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) to post quarterly earnings at $2.38 per share on revenue of $6.38 billion. The company will release earnings before the markets open. Marriott shares fell 0.3% to $303.51 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Astera Labs Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) reported upbeat financial results for the fourth quarter. The company said it expects first-quarter revenue to be in the range of $151 million to $155 million versus estimates of $134.25 million. The company anticipates adjusted earnings of 28 cents to 29 cents per share in the first quarter. Astera Labs shares declined 3.8% to $99.37 in the after-hours trading session.</li>
<li>Analysts expect Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) to post quarterly earnings at $1.70 per share on revenue of $7.14 billion after the closing bell. Gilead Sciences shares gained 0.1% to $95.60 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

ALAB

HLIT

Coca-Cola, Marriott International And 3 Stocks To Watch Heading Into Tuesday

California-based <a href="https://www.benzinga.com/25/01/43419057/rivian-expands-illinois-factory-as-it-gears-to-start-production-of-its-cheaper-r2-suv">EV startup</a> Rivian Automotive Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) will be hiking prices on its R1T electric truck and R1S electric SUV in Canada by C$10,000 (about $7000) starting Feb.25, the company said in a mail to potential customers.
What Happened: The company said the price hike is due to a change in the exchange rate between the US and Canada.
&#8220;Now&#8217;s the time to bring home a new R1,&#8221; the company wrote, urging potential customers to purchase before the price hike kicked in.
One Canadian dollar currently equals $0.70, down from $0.74 a year ago. 
Why It Matters: Rivian vehicles are not cheap even now. Both their electric SUV and truck are to the higher end, making them rather premium purchases. 
While the R1T truck starts at C$101,900, the R1S starts at C$109,900 in Canada. In comparison, Tesla&#8217;s Model Y SUV starts at just C$64,990 in the country. 
Rivian is slated to report its fourth-quarter results on Feb. 20 at 2 pm PT. 
For the full year 2024, Rivian&nbsp;<a href="https://www.benzinga.com/tech/25/01/42807694/rivian-reports-2nd-highest-quarterly-ev-deliveries-as-2024-wraps-up" target="_blank" rel="noreferrer noopener">delivered 51,579 EVs</a>, within its guidance of 50,500 to 52,000 deliveries.
In the three months through the end of December, the company delivered 14,183 vehicles, its second-highest quarterly delivery numbers since it started deliveries in 2021. &nbsp;
Rivian opened sales of its Rivian Commercial van to fleets of all sizes in the U.S. <a href="https://www.benzinga.com/news/25/02/43593007/rivian-commercial-van-now-available-for-fleets-nationwide-in-us" target="_blank" rel="noopener">on Monday</a>. The vehicle is the platform for Amaon&#8217;s custom electric delivery van. Until recently, the vans were sold only to Amazon owing to an exclusivity clause in the original agreement between the EV maker and the online retailer.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43588718/lucid-ceo-envisions-ev-maker-licensing-tech-more-than-building-cars" target="_blank" rel="noreferrer noopener">Peter Rawlinson Wants Lucid To Be The Intel Of EVs: ‘You Flash Your Microsoft Office… Bill Gates Gets His Royalty… I Want To Be Like That'</a></li>
</ul>
Photo courtesy: Shutterstock

RIVN

Rivian To Hike R1T, R1S Prices In Canada By Nearly 10% From Feb 25 Amid Exchange Rate Shift

Huawei Technologies has found an unconventional way to boost smartwatch sales in China—by registering them as medical devices.
What Happened: Huawei's Watch D2, launched in November, has gained traction in China after consumers realized they could charge it to their medical insurance accounts, <a href="https://www.bloomberg.com/news/articles/2025-02-10/huawei-sees-china-smart-watch-boom-as-subsidized-medical-device?srnd=phx-technology">reported</a> Bloomberg on Monday.
The Huawei watch costs 2,988 yuan ($409). It includes several health features, including blood pressure, sleep quality, heart rate, and step count. This qualifies it as a medical device under China's insurance system.
See Also: <a href="https://www.benzinga.com/25/02/43613962/apples-super-bowl-lix-strategy-was-discretely-genius-says-youtuber-nikias-molinaheres-how-it-stole-the-spotlight-without-selling-a-single-product">Apple&#8217;s Super Bowl LIX Strategy &#8216;Discretely Genius,&#8217; Says YouTuber Nikias Molina—Here&#8217;s How Cupertino Stole The Spotlight Without Pushing An iPhone In Your Face</a>
The move has led to high demand, with some pharmacies requiring pre-orders and limiting purchases to prevent resales.
&#8220;The watches are currently not available,&#8221; a Shanghai pharmacy told local media. &#8220;Buyers need an appointment, and over 500 people are in the queue.&#8221;
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: By branding its smartwatches as health essentials, Huawei has tapped into China's healthcare system, covering 95% of the population.
Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) Watches, despite their advanced health tracking, do not hold medical device status in China, meaning consumers must pay out of pocket.
However, Huawei's move has sparked also controversy, with concerns that more tech firms could exploit medical labeling, straining China's healthcare resources, the report noted.
Some regions, like Ningbo, have already temporarily suspended such purchases while authorities review regulations.
An IDC report revealed that Huawei led <a href="https://www.benzinga.com/24/12/42570544/apple-watch-is-getting-a-run-for-its-money-as-chinese-tech-giants-led-by-huawei-lead-20-growth-in-global-wrist-worn-device-market">smartwatch shipments with a 16.9% market share</a>, surpassing Apple's 16.2% in the first three quarters of 2024.
Xiaomi secured third place with 20.5 million shipments and a 14.7% market share. Samsung came next with 11.5 million units. The BBK Group, which owns Oppo, Vivo, OnePlus, and Realme, followed with 7.8 million.
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/02/43485288/apple-raises-monthly-applecare-prices-for-all-iphones-and-you-can-no-longer-buy-the-warranty-upfront-in-stores" target="_blank" rel="noreferrer noopener">Apple Raises Monthly AppleCare+ Prices For All iPhones— And You Can No Longer Buy The Warranty Upfront In Stores</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Media

AAPL

Apple Watch Dominance Under New Threat As Huawei Registers Smartwatch As Medical Device

Noted Economist and Strategist&nbsp;Peter Schiff&nbsp;recently opined on the current gold-to-silver ratio, suggesting a potential surge in silver prices.
What Happened: Schiff posted on X on Tuesday about the gold-to-silver ratio, which stood at over 90:1. He noted that gold, trading at $2,940, was likely to continue its upward trajectory, and predicted an &#8220;explosive catch-up move&#8221; in silver, currently priced at $32.22. He advised investors who felt they had missed the gold rally to consider buying silver.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">With gold trading at $2,940 and silver still down at $32.22, the gold-to-silver ratio is over 90 to 1. Since gold is highly likely to continue rising, an explosive catch-up move in silver is likely soon. So if you think you missed the boat on gold, just buy some silver instead.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1889134326454829160?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
SEE ALSO: <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43613481/alt-bitcoin-ethereum-dogecoin-rise-as-investors-shrug-off-trumps-tariff-order-analyst-sees-healthier-market-cycle-as-trader-interest-shifts-from-meme-coins-to-btc">Bitcoin, Ethereum, Dogecoin Rise As Investors Shrug Off Trump&#8217;s Tariff Order: Analyst Sees &#8216;Healthier Market Cycle&#8217; As Trader Interest Shifts From Meme Coins To BTC (CORRECTED)</a>
Why It Matters: Schiff&#8217;s comments come in the wake of gold&#8217;s impressive performance, which has seen it outperform Bitcoin and U.S. equities. Gold prices are <a href="https://www.benzinga.com/25/02/43590446/gold-prices-near-3000-outpacing-us-equities-as-it-hits-a-fresh-record-high-amid-donald-trumps-trade-war-led-market-uncertainty">nearing the $3,000 mark</a>, outpacing U.S. equities amid market uncertainty driven by President Donald Trump&#8216;s ongoing tariffs and trade negotiations and geopolitical uncertainties in the Middle East. However, analysts point out that consistently high interest rates may limit gold's potential gains.
Meanwhile, Silver has gained renewed attention for its role in green technologies, such as solar panels and electric vehicles, as well as its historical function as a hedge against inflation. Moreover, ongoing clashes between Ukraine and Russia, along with escalating tensions in the Middle East, may prompt investors to turn to <a href="https://www.benzinga.com/money/silver-price-forecast-short-long-term-silver-price-prediction">silver as a safe haven</a>.
In January, Ole Hansen, Head of Commodity Strategy at Saxo Bank stated, &#8220;This dual role—balancing both investment and industrial demand—could enable silver to outperform gold in the coming year.&#8221; He forecasted silver prices to rise to $38 per ounce this year. Also, analysts at UBS foresee silver prices to reach between $36 and $38 per ounce in 2025.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/news/25/02/43607699/no-we-are-not-taking-over-gaza-says-influential-congresswoman-warns-trumps-real-goal-is-helping-billionaires-gut-programs-for-americans">&#8216;No, We Are Not Taking Over Gaza,&#8217; Says Influential Congresswoman—Warns Trump&#8217;s Real Goal Is Helping Billionaires Gut Programs For Americans</a></li>
</ul>

Commodities

Peter Schiff Says Silver Is Set For An 'Explosive' Rally As Yellow Metal Nears $3,000: 'If You Think You Missed The Boat On Gold'

Stora Enso (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SEOAY#OTC">SEOAY</a>) reported quarterly losses of $(0.86) per share. This is a 25.22 percent decrease over losses of $(0.69) per share from the same period last year. The company reported $2.48 billion in sales this quarter. This is a 5.90 percent increase over sales of $2.34 billion the same period last year.

SEOAY

Stora Enso Q4 Adj. EPS $(0.86) Down From $(0.69) YoY, Sales $2.48B Up From $2.34B YoY

2025 guidance&nbsp;
• bp expects reported upstream&#x2A; production to be lower and underlying upstream production&#x2A; to be slightly lower compared with 2024. Within this, bp expects underlying production from oil production &amp; operations to be broadly flat and production from gas &amp; low carbon energy to be lower.&nbsp;
• In its customers business, bp expects growth in its customers businesses including a full year contribution from bp bioenergy and a higher contribution from TravelCenters of America in part supported by a partial recovery from the US freight recession. Earnings growth is expected to be supported by structural cost reduction. bp continues to expect fuels margins to remain sensitive to the cost of supply and earnings delivery to remain sensitive to the relative strength of the US dollar.&nbsp;
• In products, bp expects broadly flat refining margins relative to 2024 and stronger underlying performance underpinned by the absence of the plant-wide power outage at Whiting refinery, and improvement plans across the portfolio. bp expects similar levels of refinery turnaround activity, with phasing of turnaround activity in 2025 heavily weighted towards the first half, with the highest impact in the second quarter.&nbsp;
• bp expects other businesses &amp; corporate underlying annual charge to be around $1.0 billion for 2025. The charge may vary from quarter to quarter.&nbsp;
• bp expects the depreciation, depletion and amortization to be broadly flat compared with 2024.&nbsp;
• bp expects the underlying ETR&#x2A; for 2025 to be around 40% but it is sensitive to a range of factors, including the volatility of the price environment and its impact on the geographical mix of the group's profits and losses.&nbsp;
• bp expects divestment and other proceeds to be around $3 billion in 2025 weighted towards the second half. Having realized $22.0 billion of divestment and other proceeds since the second quarter of 2020, bp continues to expect to reach $25 billion of divestment and other proceeds between the second half of 2020 and 2025.&nbsp;
• bp expects Gulf of America settlement payments for the year to be around $1.2 billion pre-tax including $1.1 billion pre-tax to be paid during the second quarter.

Guidance

BP 2025 Guidance: Flat Oil Production, Lower Gas Output, Stable Refining Margins, And $3B In Asset Sales By Year-End

Prominent Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) investors are weighing in on the increasingly competitive autonomous driving landscape as Chinese rivals BYD Co. Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) and Huawei advance their driver assistance systems, challenging Tesla&#8217;s vision-only approach.
What Happened: Ross Gerber, CEO of Gerber Kawasaki Wealth and Investment Management, highlighted a key technical distinction in the autonomous driving race, noting on X that all major competitors &#8220;use LIDAR&#8221; technology, contrasting with Tesla&#8217;s camera-only system. 
His observation comes amid recent concerns about Tesla&#8217;s Full Self-Driving (FSD) system&#8217;s limitations, including its vulnerability to <a href="https://www.benzinga.com/markets/equities/25/01/43329365/a-day-after-elon-musk-hailed-teslas-unsupervised-fsd-ross-gerber-criticizes-ev-makers-autonomous-driving-system-doesnt-work-when-dust-or-ash-get-in-the-cameras">dust, ash, and sun glare</a>.
Gary Black, managing partner of The Future Fund LLC, suggests that autonomous driving is becoming &#8220;commoditized&#8221; rather than a winner-take-all market. &#8220;We own TSLA as the global EV leader as EV adoption soars, and we get upside from unsupervised autonomy and Optimus. But we don&#8217;t own TSLA because of any misplaced view it will take 100% share of ride sharing,&#8221; Black stated on X.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">All use LIDAR
&mdash; Ross Gerber (@GerberKawasaki) <a href="https://twitter.com/GerberKawasaki/status/1888962659783217317?ref_src=twsrc%5Etfw">February 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/02/43613306/ios-1831-released-with-critical-security-fix-apple-confirms-usb-restricted-mode-vulnerability-was-actively-exploited">iOS 18.3.1 Released With Critical Security Fix: Apple Confirms USB Restricted Mode Vulnerability Was Actively Exploited</a>
Why It Matters: The debate intensifies as BYD introduces its &#8220;God&#8217;s Eye&#8221; advanced driver assistance system across its entire lineup, including its budget Seagull hatchback priced at approximately $9,600. 
Meanwhile, Huawei&#8217;s Qiankun ADS 3.2 system, demonstrated in recent reviews, has shown promising performance in complex urban environments, featuring HD map-free smart driving and omnidirectional collision avoidance capabilities.
Tesla CEO Elon Musk continues to defend the company&#8217;s vision-only approach, recently stating, &#8220;Obviously, humans drive without shooting lasers out of their eyes.&#8221; However, this stance faces scrutiny as the National Highway Traffic Safety Administration investigates 2.6 million Tesla vehicles <a href="https://www.benzinga.com/25/01/43327837/tesla-ceo-elon-musk-dismises-lidar-again-says-if-humans-drive-without-shooting-lasers-from-their-eyes-so-can-autonomous-cars">equipped with FSD technology</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/43613133/trumps-25-tarrifs-a-self-inflicted-wound-says-economist-amid-warnings-of-fewer-american-jobs-peter-schiff-says-youll-pay-more-for-cars-and-homes">Trump&#8217;s 25% Tariffs A &#8216;Self-Inflicted Wound,&#8217; Says Economist Amid Warnings Of Fewer American Jobs — Peter Schiff Says You&#8217;ll Pay More For Cars And Homes </a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

BYDDY

GOOGL

UBER

BYD's 'God's Eye' And Huawei's Autonomous Driving Progress Spark Concerns For Tesla: Ross Gerber Points Out, 'All Use LIDAR'

1Q 2025 guidance&nbsp;
• Looking ahead, bp expects first quarter 2025 reported upstream&#x2A; production to be lower compared with the fourth-quarter 2024 primarily due to the already announced divestments in Egypt and Trinidad, which completed towards the end of the fourth quarter and base decline in both regions, totaling around 90 thousand barrels of oil equivalent per day.&nbsp;
• In its customers business, bp expects seasonally lower volumes compared to the fourth quarter.&nbsp;In addition, bp expects fuels margins to remain sensitive to movements in cost of supply and earnings delivery to remain sensitive to the relative strength of the US dollar.&nbsp;
• In products, bp expects realized refining margins to remain low in the first quarter. bp also expects a lower level of refinery turnaround activity compared to the fourth quarter 2024.

BP 1Q Guidance: Upstream Headwinds From Egypt And Trinidad Divestitures, Soft Refining Margins, And Seasonal Weakness In Customer Business To Weigh On Performance

BP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.47 by 6.38 percent. This is a 58.88 percent decrease over earnings of $1.07 per share from the same period last year. The company reported quarterly sales of $45.752 billion which missed the analyst consensus estimate of $47.511 billion by 3.70 percent. This is a 12.25 percent decrease over sales of $52.141 billion the same period last year.

Earnings Misses

BP Q4 2024 Adj. EPS $0.44 Misses $0.47 Estimate, Sales $45.752B Miss $47.511B Estimate

Reflects the promise of the novel Factor XI inhibitor class of medicines to help prevent strokes and other conditions as well as Abelacimab's potential to provide superior safety
Culminates growth journey as part of Blackstone Life Science

Blackstone-Backed Anthos Therapeutics To Be Acquired By Novartis In $3.1B Deal, Advancing Factor XI Inhibitor Therapy

TD currently holds 184,678,738 shares of Schwab's common stock representing 10.1% economic ownership. The Bank will sell 165,443,530 shares through a registered offering at a price of US$79.25 per share. Schwab will purchase 19,235,208 shares from the Bank for a total purchase price of US$1.5 billion. The sale is expected to close on February 12, 2025, subject to customary closing conditions.
The transaction will generate net proceeds of approximately C$20 billion after taxes and underwriting discount with C$15 billion in CET1 capital created or 247 bps of CET1 capital released.

SCHW

TD Bank Group Prices Sale Of 184.7M Schwab Shares At $79.25 Each, Unlocking C$20B In Proceeds And Launching Share Buyback Program

LILA

Reported Earlier, Liberty Latin America's C&W Completes $755M Senior Notes Issuance, Extending Debt Maturities Beyond 2032

Biodexa Pharmaceuticals (BDRX) announces that at its General Meeting held earlier, both resolutions put to the Company's shareholders were duly pas...

Biodexa Pharmaceuticals announces result of general meeting

Biodexa Pharmaceuticals (BDRX) has released an update. Biodexa Pharmaceuticals has successfully passed resolutions at its General Meeting to reduce...

Biodexa Pharmaceuticals Adjusts Share Value Amid Drug Development Focus

Ladenburg raised the firm's price target on Biodexa Pharmaceuticals (BDRX) to $18 from $8 and keeps a Buy rating on the shares. The company recentl...

Biodexa Pharmaceuticals price target raised to $18 from $8 at Ladenburg

Biodexa Pharmaceuticals files to sell 35.9M ADS for holders

16:52 EST Biodexa Pharmaceuticals (BDRX) files to sell 35.875M ADS for holders Published first on TheFly – the ultimate source for real-time, marke...

Biodexa Pharmaceuticals files to sell 35.875M ADS for holders

Biodexa Pharmaceuticals ( ($BDRX) ) has issued an announcement. On January 17, 2025, Biodexa Pharmaceuticals entered into a securities purchase agr...

Biodexa Pharmaceuticals Secures Flexible $35 Million Funding Agreement

Biodexa Pharmaceuticals (BDRX) announced the appointment of Dr Gary Shangold as Chief Medical Officer with immediate effect. Most recently, Shangol...

Biodexa Pharmaceuticals appoints Shangold as Chief Medical Officer

Biodexa appoints Gary A. Shangold as Chief Medical Officer

The latest update is out from Biodexa Pharmaceuticals ( ($BDRX) ). Biodexa Pharmaceuticals announced the appointment of Dr. Gary A. Shangold as Chi...

Biodexa Pharmaceuticals Enhances Leadership with New Chief Medical Officer

Biodexa stock soars 76% on FDA Fast Track status for eRapa

BDRX

SWKH

Image

Biotech

Gaining Momentum, Biodexa Is Advancing Two Recent Acquisitions Through The Clinic

Untitled design - 2024-10-16T235234.675

Biodexa&#39;s MX-110 Continues To Show Promise In Recurrent Glioblastoma (rGBM), The Deadliest Brain Cancer

Screenshot 2024-07-10 at 9.15.35 PM

Biodexa Announces Additional Positive Results Of Phase 2 Trial Of eRapa In Treatment Of Precancerous Polyps In The GI Tract – Now 12-Month Data

Screenshot 2024-06-03 at 5.21.04 PM

Promising Phase 2 Results For Biodexa&#39;s eRapa™ Indicates Hope For FAP Patients Who Otherwise Have A 100% Lifetime Risk Of Colorectal Cancer

Screenshot 2024-05-08 at 7.48.00 PM

Biodexa Looks To Prevent Or Delay The Worst Outcomes For Adolescents And Young Adults With Devastating Precancerous Condition

Untitled design - 2024-03-28T172702.605

Biodexa&#39;s MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers

Redington 2_29

PowerShares Dynamic Financial Sector Portfolio

Biodexa Takes Aim At Type 1 Diabetes With Innovative Drug Candidate Tolimidone

Legal

Press Releases

BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biodexa Pharmaceuticals Plc - BDRX

Notice of General Meeting

Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company")  Regains Compliance For Continued Listing on Nasdaq

Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic

Cardiol Therapeutics (Nasdaq: CRDL) Advances Orphan Drug Designation for CardiolRx™ at the American Heart Association…more stocks inside…

Result of General Meeting

Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer

Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis

Comments

Biodexa Pharmaceuticals

Biodexa Pharmaceuticals (BDRX) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌